Pro-Dex (PDEX) Competitors $40.71 -1.63 (-3.85%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$40.78 +0.06 (+0.16%) As of 08/14/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. EMBC, AXGN, ZIMV, BVS, CBLL, AVNS, KIDS, SMLR, SI, and DCTHShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Embecta (EMBC), AxoGen (AXGN), ZimVie (ZIMV), Bioventus (BVS), CeriBell (CBLL), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), Semler Scientific (SMLR), Shoulder Innovations (SI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Embecta AxoGen ZimVie Bioventus CeriBell AVANOS MEDICAL OrthoPediatrics Semler Scientific Shoulder Innovations Delcath Systems Pro-Dex (NASDAQ:PDEX) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Is PDEX or EMBC more profitable? Pro-Dex has a net margin of 14.61% compared to Embecta's net margin of 7.58%. Pro-Dex's return on equity of 29.08% beat Embecta's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex14.61% 29.08% 16.19% Embecta 7.58%-23.40%14.46% Do insiders & institutionals believe in PDEX or EMBC? 15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 47.5% of Pro-Dex shares are held by company insiders. Comparatively, 0.4% of Embecta shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings & valuation, PDEX or EMBC? Embecta has higher revenue and earnings than Pro-Dex. Embecta is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$53.84M2.46$2.13M$2.8014.54Embecta$1.12B0.72$78.30M$1.439.70 Which has more risk & volatility, PDEX or EMBC? Pro-Dex has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Comparatively, Embecta has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Do analysts prefer PDEX or EMBC? Pro-Dex presently has a consensus target price of $56.00, suggesting a potential upside of 37.56%. Embecta has a consensus target price of $19.00, suggesting a potential upside of 36.99%. Given Pro-Dex's stronger consensus rating and higher probable upside, equities research analysts clearly believe Pro-Dex is more favorable than Embecta.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Embecta 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media refer more to PDEX or EMBC? In the previous week, Embecta had 15 more articles in the media than Pro-Dex. MarketBeat recorded 16 mentions for Embecta and 1 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.88 beat Embecta's score of 0.55 indicating that Pro-Dex is being referred to more favorably in the media. Company Overall Sentiment Pro-Dex Very Positive Embecta Positive SummaryPro-Dex beats Embecta on 10 of the 15 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$138.07M$15.04B$5.61B$9.84BDividend YieldN/A1.48%4.61%4.07%P/E Ratio14.5417.8930.2825.74Price / Sales2.462.43460.47115.79Price / Cash44.2216.2838.2159.48Price / Book4.513.708.856.15Net Income$2.13M$430.42M$3.25B$265.06M7 Day Performance-14.74%-0.17%3.72%2.60%1 Month Performance-9.89%3.13%5.86%2.83%1 Year Performance109.63%13.40%30.34%25.58% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex3.2549 of 5 stars$40.71-3.8%$56.00+37.6%+118.1%$138.07M$53.84M14.54140Positive NewsEMBCEmbecta4.7427 of 5 stars$9.79-1.7%$19.00+94.1%-6.0%$582.09M$1.08B10.882,100Earnings ReportAXGNAxoGen2.9182 of 5 stars$12.55-0.9%$24.50+95.2%+38.6%$577.04M$187.34M-83.66450Short Interest ↑ZIMVZimVie0.4513 of 5 stars$18.77+0.1%$17.75-5.4%+13.6%$529.05M$449.75M-26.811,770Short Interest ↑BVSBioventus3.017 of 5 stars$6.32+2.3%$13.75+117.6%-8.3%$519.15M$567.70M-10.361,200CBLLCeriBell2.4813 of 5 stars$15.23+7.7%$32.14+111.0%N/A$511.06M$65.44M0.00N/AAVNSAVANOS MEDICAL1.7701 of 5 stars$11.28+2.7%N/A-51.4%$507.76M$687.80M-1.352,227Short Interest ↑KIDSOrthoPediatrics3.9917 of 5 stars$20.53+0.7%$35.83+74.5%-24.5%$495.20M$204.73M-11.73200SMLRSemler Scientific3.3206 of 5 stars$35.37+2.6%$82.00+131.8%+25.1%$475.15M$56.29M-13.55120Gap UpSIShoulder InnovationsN/A$14.35+0.7%N/AN/A$454.31M$34.57M-0.4861Positive NewsDCTHDelcath Systems2.6732 of 5 stars$11.27+6.4%$24.00+113.0%+42.3%$368.81M$37.21M-22.5460Short Interest ↑ Related Companies and Tools Related Companies EMBC Competitors AXGN Competitors ZIMV Competitors BVS Competitors CBLL Competitors AVNS Competitors KIDS Competitors SMLR Competitors SI Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.